Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01902173
Title Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)

Advanced Solid Tumor



Dabrafenib + Trametinib + Uprosertib

Dabrafenib + Uprosertib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
USC / Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
UCLA / Jonsson Comprehensive Cancer Center Los Angeles California 90095 United States Details
California Pacific Medical Center-Pacific Campus San Francisco California 94115 United States Details
UCSF Medical Center-Mount Zion San Francisco California 94115 United States Details
University of Colorado Hospital Aurora Colorado 80045 United States Details
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109 United States Details
Cleveland Clinic Foundation Cleveland Ohio 44195 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
Clackamas Radiation Oncology Center Clackamas Oregon 97015 United States Details
Providence Milwaukie Hospital Milwaukie Oregon 97222 United States Details
Providence Newberg Medical Center Newberg Oregon 97132 United States Details
Providence Willamette Falls Medical Center Oregon City Oregon 97045 United States Details
Providence Portland Medical Center Portland Oregon 97213 United States Details
Providence Saint Vincent Medical Center Portland Oregon 97225 United States Details
Oregon Health and Science University Portland Oregon 97239 United States Details
PeaceHealth Southwest Medical Center Vancouver Washington 98664 United States Details
*Shaded cells indicate that there was no data available from for the field